Greater Boston’s Life Science Market Is Recalibrating for Growth
Vacancy reached a new all-time high of 36.1 percent and asking rents continued to decline. But green shoots give reason for hope.
Signs of Life in Boston Biotech CRE
Little tiny green shoots are poking up here and there, with leasing activity running well ahead of 2024 totals and the pace of vacancy growth slowing down.
Beacon Hill Must Keep Biotech’s Flywheel Turning
To maintain Massachusetts’ leadership in global drug development, we cannot allow uncertainty and alarm bells coming from its biotech sector to paralyze us.
What’s Driving Transaction Activity in 2025
With vacancy rates elevated, demand softening and pricing still under pressure, the relative appeal of ownership has only grown. And it’s leading driving some major transactions.
Don’t Bet on Filling Those Lab Buildings Any Time Soon
The Bay State’s life sciences sector now faces the prospect of a potential retrenchment amid slashing cuts to research funding and drops in venture capital funding.
Boston’s Lab Market Faced Glut of Space. Now It’s Got a Shrinking Tenant Pool, Too
An annual state-of-the-industry report by Massachusetts’ main biotech trade group is full of unwelcome news to developers, investors and lenders exposed to the state’s life science real estate market.
Here Comes Trump to Further Wreck Boston’s Lab Real Estate Market
The battered life sciences sector is already sitting on enough empty lab space to fill 16 Prudential towers. Now, the Trump administration’s plans to cut billions in research grants will make the sector even worse.
The Biggest Boston Real Estate Stories You Missed This Summer
The local real estate markets may be a lot less busy now than a few years ago, but that didn’t mean this summer was a snooze-fest of real estate news. Here’s a rundown on the six biggest stories you might have missed between vacations and the interminable wait for the Fed to start cutting interest rates.
Sublease Surge Puts Pressure on Lab Rents
Asking rents for life science space in Greater Boston have declined 10 percent from 2022’s peak and landlords are likely to offer further concessions amid a recent uptick in sublease space.
Alexandria Sees Rebound in Lab Space Demand
Greater Boston’s largest lab landlord said vacancies in its local portfolio topped 7 percent in the fourth quarter, but a revival in life science industry expansion plans points to growth in 2024.
Is Something Frightening Hiding in REIT’s Retrenchment?
Moves by the California-based Alexandria Real Estate Equities to dump a significant slice of its Boston-area life science real estate portfolio speak volumes about the state of the local lab market, none of it good.
